Industry Payments to Physicians by Competing Manufacturers Within Novel Therapeutic Classes

This study analyzes the extent and persistence of payments to physicians from competing manufacturers after receipt of payment from manufacturers of first-in-class products entering 6 novel therapeutic classes.

Authors

Qisi Sun (ORCID: https://orcid.org/0000-0002-0024-5441)
Joseph S. Ross (ORCID: https://orcid.org/0000-0002-9218-3320)

Institutions

Yale University (US)
Yale New Haven Health System (US)

Publication Details

Journal: JAMA
Published: 2024-11-07
DOI: https://doi.org/10.1001/jama.2024.20842
Citations: 4
Primary Topic: Pharmaceutical industry and healthcare
Type: article
Field-Weighted Citation Impact: 1.87

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Industry Payments to Physicians by Competing Manufacturers Within Novel Therapeutic Classes

Qisi Sun, Joseph S. Ross

Nov 7, 2024

4 citations

JAMA

Pharmaceutical industry and healthcare

1.87

article

Industry Payments to Physicians by Competing Manufacturers Within Novel Therapeutic Classes

Qisi Sun, Joseph S. Ross

November 7, 2024article en

4 citations

Abstract

JAMAVol. 332(24)

Yale University (US), Yale New Haven Health System (US)

Openalex Percentile: Top 15%

Pharmaceutical industry and healthcare

1.87

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Industry Payments to Physicians by Competing Manufacturers Within Novel Therapeutic Classes — Qisi Sun, Joseph S. Ross · JAMA (2024) | TGRS Research Map | TGRS